MiR-630 inhibits proliferation by targeting CDC7 kinase, but maintains the apoptotic balance by targeting multiple modulators in human lung cancer A549 cells.
about
MicroRNAs Used in Combination with Anti-Cancer Treatments Can Enhance Therapy EfficacyIn silico identification of potential key regulatory factors in smoking-induced lung cancer.Novel Epigenetic CREB-miR-630 Signaling Axis Regulates Radiosensitivity in Colorectal CancerAirway Secretory microRNAome Changes during Rhinovirus Infection in Early ChildhoodMicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinomaCandida albicans Dbf4-dependent Cdc7 kinase plays a novel role in the inhibition of hyphal development.Altered Expressions of miR-1238-3p, miR-494, miR-6069, and miR-139-3p in the Formation of Chronic BrucellosisIdentification of miRNA-mRNA crosstalk in CD4+ T cells during HIV-1 infection by integrating transcriptome analyses.PDGFR-alpha inhibits melanoma growth via CXCL10/IP-10: a multi-omics approach.MiR-630 inhibits invasion and metastasis in esophageal squamous cell carcinoma.MicroRNA hsa-miR-25-3p suppresses the expression and drug induction of CYP2B6 in human hepatocytes.MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas.DNA Damage Inducible Transcript 4 Gene: The Switch of the Metabolism as Potential Target in Cancer.A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop.MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2.
P2860
Q28829013-53307F67-0DA2-44D1-BCA4-77412CACB287Q33776567-C6F5A4DA-DB5D-46BB-91EE-85FF6282A706Q35742738-E2F60DB2-C48D-4A9F-BAF6-94FD102058C2Q36137094-5C4BEC26-8168-4BD4-BAB4-C5A6E9B5AC55Q37225640-EB57D8D2-A72A-41C6-93BD-F43EE71104E5Q37267170-A27F8D55-EC10-4AEA-8929-14BE00070460Q37303265-E20AD2A2-7A1D-4248-8D0C-AD87C792D256Q37655340-4E63D3DD-8870-43D9-BCDD-E586E6D7B94CQ37718362-F8BB4776-B790-427D-BF71-A11A69F8F964Q38749995-5C242723-2AF6-4545-8B6D-05ED47D03C6DQ38764044-BF5400AA-F0DC-444B-9202-282E8BB77977Q49409530-5C896DF0-463F-4A9B-9329-B502F65E12BCQ53690290-6ADFFC26-AFA0-4375-8819-888B3F9C6C82Q54939484-5261E327-730E-47D1-9EE2-85818DA166DAQ55410765-0B53AADB-2F3E-41E3-BF94-3C7F60E84430
P2860
MiR-630 inhibits proliferation by targeting CDC7 kinase, but maintains the apoptotic balance by targeting multiple modulators in human lung cancer A549 cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
MiR-630 inhibits proliferation ...... human lung cancer A549 cells.
@ast
MiR-630 inhibits proliferation ...... human lung cancer A549 cells.
@en
MiR-630 inhibits proliferation ...... human lung cancer A549 cells.
@nl
type
label
MiR-630 inhibits proliferation ...... human lung cancer A549 cells.
@ast
MiR-630 inhibits proliferation ...... human lung cancer A549 cells.
@en
MiR-630 inhibits proliferation ...... human lung cancer A549 cells.
@nl
prefLabel
MiR-630 inhibits proliferation ...... human lung cancer A549 cells.
@ast
MiR-630 inhibits proliferation ...... human lung cancer A549 cells.
@en
MiR-630 inhibits proliferation ...... human lung cancer A549 cells.
@nl
P2093
P2860
P356
P1476
MiR-630 inhibits proliferation ...... human lung cancer A549 cells.
@en
P2093
P2860
P356
10.1038/CDDIS.2014.386
P577
2014-09-25T00:00:00Z